Walgreens Boots Alliance, Inc. (WBA)
Market Cap | 9.90B |
Revenue (ttm) | 150.41B |
Net Income (ttm) | -8.83B |
Shares Out | 864.15M |
EPS (ttm) | -10.24 |
PE Ratio | n/a |
Forward PE | 7.44 |
Dividend | $1.00 (8.73%) |
Ex-Dividend Date | Nov 18, 2024 |
Volume | 591,707 |
Open | 11.28 |
Previous Close | 11.25 |
Day's Range | 11.25 - 11.52 |
52-Week Range | 8.08 - 23.77 |
Beta | 0.62 |
Analysts | Hold |
Price Target | 13.27 (+15.79%) |
Earnings Date | Jan 10, 2025 |
About WBA
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of p... [Read more]
Financial Performance
In 2024, Walgreens Boots Alliance's revenue was $147.66 billion, an increase of 6.17% compared to the previous year's $139.08 billion. Losses were -$8.64 billion, 180.4% more than in 2023.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for WBA stock is "Hold." The 12-month stock price forecast is $13.27, which is an increase of 15.79% from the latest price.
News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Walgreens Boots Alliance, Inc. (WBA) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or ...
Walgreens Announcement: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA)...
Bronstein, Gewirtz & Grossman, LLC Encourages Walgreens Boots Alliance, Inc. (WBA) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / January 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or ...
Walgreens Stock Tumbles. Report Says Private-Equity Bid for Pharmacy Chain ‘Mostly Dead.
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Walgreens Boots Alliance, Inc. (WBA) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or ...
Walgreens Investor News: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 25, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA)...
Is it safe to buy these high-yielding S&P 500 stocks?
The S&P 500 index has been one of the best-performers of all time. Launched in 1950s when it was trading at $45.4, the blue-chip index has surged to over $6,100.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Walgreens Boots Alliance, Inc. (WBA) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Walgreens Boots Alliance, Inc. (WBA) And Encourages Stockholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA). Investors who purchased Walg...
Walgreens Boots Alliance, Inc. (WBA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA). Investors who purchased Walg...
Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound
After a tough year for Walgreens (WBA) investors in 2024, shares may have appeared poised to start 2025 on strong note after the company's first-quarter results topped expectations.
S&P 500 Gains and Losses Today: Walgreens Stock Plummets as DOJ Files Lawsuit
Major U.S. equities indexes advanced as the markets kicked off a shortened trading week following the Martin Luther King Jr. holiday and President Donald Trump's inauguration.
Walgreens Stock Tumbles on DOJ Lawsuit Over 'Millions' of Alleged Illegal Prescriptions
Walgreens Boots Alliance (WBA) shares sank Tuesday, the first day of trading since the Department of Justice (DOJ) on Friday announced a lawsuit accusing the pharmacy chain of dispensing "millions of ...
Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis
Last week, the U.S. Department of Justice filed a civil complaint against Walgreens Boots Alliance Inc WBA and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) a...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Walgreens Boots Alliance, Inc. (WBA) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA). Investors who purchased Walg...
New Oriental Education, Walgreens And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Tuesday.
Bronstein, Gewirtz & Grossman, LLC Encourages Walgreens Boots Alliance, Inc. (WBA) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or ...
Justice Department Sues Walgreens Over Unlawful Opioid Prescriptions
The Justice Department has filed a civil complaint against Walgreens which operates more than 8,000 pharmacies throughout the United States alleging that they dispensed millions of illegal prescriptio...
Walgreens Stock Drops on News of DOJ Lawsuit Alleging Pharmacy Filled Millions of Prescriptions Without Legitimate Medical Purpose - Kehoe Law Firm, P.C. Investigating - WBA
PHILADELPHIA, PA / ACCESS Newswire / January 18, 2025 / Kehoe Law Firm, P.C. is investigating securities class action claims on behalf of shareholders of Walgreens Boots Alliance, Inc. ("Walgreens" or...
7 Stocks I'm Buying Amid This Goldilocks (For Now) Economy
There is an often overlooked difference between income investing and dividend growth investing. The two are not the same. Timely charts showing that inflation is even more subdued than the official CP...
INVESTIGATION ALERT (NASDAQ: WBA): DiCello Levitt LLP Is Investigating Investor Claims Against Walgreens Boots Alliance, Inc. and Encourages WBA Investors with Losses to Contact the Firm
SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) violated the fede...
Walgreens stock sinks after DOJ sues over illegal-prescription accusations
The pharmacy “allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores,” the Justice Department said.
U.S. Sues Walgreens for Role in Opioid Crisis
The pharmacy chain since August 2012 filled prescriptions that lacked a legitimate medical purpose, were invalid or weren't issued in professional practice, the Justice Department said.
DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against Walgreens
WASHINGTON--(BUSINESS WIRE)--Yesterday, the United States Department of Justice (DOJ) filed a complaint in intervention in four separate whistleblower lawsuits brought by whistleblowers under the Cont...